Semarion bags $3.8M to expand a cell-based drug discovery platform
Semarion, a University of Cambridge spin-out originating from the Cavendish Laboratory, has raised $3.8 million (£2.9 million) to advance its cell assay technology and support broader adoption across the pharmaceutical industry.

The best Articles in our Network